Keythera Pharmaceuticals_Life Sciences_YIJING CAPITAL

Keythera Pharmaceuticals
Keythera Pharmaceuticals is a clinical-stage biotech fim focused on pioneering small molecule drugs that efectively combatcancers and autoimmune disorders. To build a robust portfolio of products, the company emplys a strategy that leverages itsaffinity based high throughput screening technological platform. By doing so, the company aims to expedite the process ofdiscovering and developing new drugs while also ensuring distinctiveness within its product pipelines
Keythera Pharmaceuticals
We Look Forward to Hearing from You
Discovering talent, investing in the future, and growing with visionary entrepreneurs

Submit BP

Yijing Capital focuses on innovative companies in frontier technology, life sciences, and related fields. Please complete the basic project information and upload the latest version of your business plan (BP). Our investment team will evaluate the materials and contact projects that align with our investment focus.

All submitted materials will be used solely for investment evaluation. We will strictly protect your business information.

Thank you for your trust in Yijing Capital.
We have received your business plan. After completing an initial evaluation, our investment team will contact projects that align with our investment focus. Due to the volume of submissions, we appreciate your understanding if you do not receive a follow-up. We wish your project every success!

OK